Cipla Recalls Azacitidine Injection Vials Due to Sterility Concerns
Cipla is recalling 2,151 vials of Azacitidine for Injection due to potential sterility issues caused by improper sealing.
- Product
- Azacitidine for Injection 100 mg/vial For Subcutaneous and Intravenous Use Only Single-Dose Vial Manufactured by Shilpa Medicare Limited Jadcherla -509301 INDIA Distributed by: Cipla USA, Inc. 10 Independence Blvd, Suite 300 Warren, NJ 07059 NDC 69097-805-40
- Category
- Drug
- Distribution
- Distributed nationwide